Atlas Trials

The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile

Clinical trial NCT06083961 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06083961
Sponsor
Sun U. Kwon
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Stroke, Acute IschemicPCSK9 Inhibitor
Start date
2023-10-15
Primary completion
2026-10-15
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.